Bacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma
Clinical trial NCT00794950 · COMPLETED
Trial details
- NCT number
- NCT00794950
- Sponsor
- University of Michigan
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2016-08-22
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.